source name	characteristics[organism]	characteristics[organism part]	characteristics[pooled sample]	characteristics[cell type]	characteristics[cell line]	characteristics[developmental stage]	characteristics[disease]	characteristics[ancestry category]	characteristics[sex]	characteristics[age]	characteristics[biological replicate]	Material Type	assay name	technology type	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	Factor Value[disease]	Factor Value[depletion]	Factor Value[fractionation method]
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 1	proteomic profiling by mass spectrometry	20150905_DE_benign_F1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F1_1.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 2	proteomic profiling by mass spectrometry	20150905_DE_benign_F2_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F2_1.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 3	proteomic profiling by mass spectrometry	20150905_DE_benign_F3_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F3_1.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 4	proteomic profiling by mass spectrometry	20150905_DE_benign_F4_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F4_1.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 5	proteomic profiling by mass spectrometry	20150905_DE_benign_F5_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F5_1.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 6	proteomic profiling by mass spectrometry	20150905_DE_benign_F6_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F6_1.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 7	proteomic profiling by mass spectrometry	20150905_DE_benign_F1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F1_2.raw	2	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 8	proteomic profiling by mass spectrometry	20150905_DE_benign_F2_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F2_2.raw	2	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 9	proteomic profiling by mass spectrometry	20150905_DE_benign_F3_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F3_2.raw	2	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 10	proteomic profiling by mass spectrometry	20150905_DE_benign_F4_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F4_2.raw	2	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 11	proteomic profiling by mass spectrometry	20150905_DE_benign_F5_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F5_2.raw	2	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 12	proteomic profiling by mass spectrometry	20150905_DE_benign_F6_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F6_2.raw	2	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 13	proteomic profiling by mass spectrometry	20150905_DE_benign_F1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F1_3.raw	3	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 14	proteomic profiling by mass spectrometry	20150905_DE_benign_F2_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F2_3.raw	3	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 15	proteomic profiling by mass spectrometry	20150905_DE_benign_F3_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F3_3.raw	3	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 16	proteomic profiling by mass spectrometry	20150905_DE_benign_F4_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F4_3.raw	3	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 17	proteomic profiling by mass spectrometry	20150905_DE_benign_F5_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F5_3.raw	3	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 1	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 18	proteomic profiling by mass spectrometry	20150905_DE_benign_F6_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_benign_F6_3.raw	3	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 19	proteomic profiling by mass spectrometry	20150905_DE_cancer_F1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F1_1.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 20	proteomic profiling by mass spectrometry	20150905_DE_cancer_F2_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F1_2.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 21	proteomic profiling by mass spectrometry	20150905_DE_cancer_F3_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F1_3.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 22	proteomic profiling by mass spectrometry	20150905_DE_cancer_F4_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F2_1.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 23	proteomic profiling by mass spectrometry	20150905_DE_cancer_F5_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F2_2.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 24	proteomic profiling by mass spectrometry	20150905_DE_cancer_F6_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F2_3.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 25	proteomic profiling by mass spectrometry	20150905_DE_cancer_F1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F3_1.raw	2	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 26	proteomic profiling by mass spectrometry	20150905_DE_cancer_F2_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F3_2.raw	2	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 27	proteomic profiling by mass spectrometry	20150905_DE_cancer_F3_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F3_3.raw	2	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 28	proteomic profiling by mass spectrometry	20150905_DE_cancer_F4_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F4_1.raw	2	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 29	proteomic profiling by mass spectrometry	20150905_DE_cancer_F5_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F4_2.raw	2	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 30	proteomic profiling by mass spectrometry	20150905_DE_cancer_F6_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F4_3.raw	2	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 31	proteomic profiling by mass spectrometry	20150905_DE_cancer_F1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F5_1.raw	3	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 32	proteomic profiling by mass spectrometry	20150905_DE_cancer_F2_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F5_2.raw	3	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 33	proteomic profiling by mass spectrometry	20150905_DE_cancer_F3_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F5_3.raw	3	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 34	proteomic profiling by mass spectrometry	20150905_DE_cancer_F4_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F6_1.raw	3	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 35	proteomic profiling by mass spectrometry	20150905_DE_cancer_F5_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F6_2.raw	3	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 2	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 36	proteomic profiling by mass spectrometry	20150905_DE_cancer_F6_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150905_DE_cancer_F6_3.raw	3	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 37	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F1_1.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 38	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F2_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F2_1.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 39	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F3_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F3_1.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 40	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F4_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F4_1.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 41	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F5_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F5_1.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 42	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F6_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F6_1.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 43	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F1_2.raw	2	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 44	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F2_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F2_2.raw	2	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 45	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F3_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F3_2.raw	2	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 46	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F4_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F4_2.raw	2	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 47	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F5_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F5_2.raw	2	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 48	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F6_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F6_2.raw	2	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 49	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F1_3.raw	3	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 50	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F2_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F2_3.raw	3	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 51	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F3_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F3_3.raw	3	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 52	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F4_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F4_3.raw	3	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 53	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F5_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F5_3.raw	3	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 3	Homo sapiens	ascitic fluid	B-Pool 1	not applicable	not applicable	not available	benign disease	not available	not available	not available	1	tissue	run 54	proteomic profiling by mass spectrometry	20150829_NoDE_benign_high_F6_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_benign_high_F6_3.raw	3	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	benign disease	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 55	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F1_1.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 56	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F2_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F1_2.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 57	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F3_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F1_3.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 58	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F4_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F2_1.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 59	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F5_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F2_2.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 60	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F6_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F2_3.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 61	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F3_1.raw	2	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 62	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F2_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F3_2.raw	2	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 63	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F3_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F3_3.raw	2	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 64	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F4_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F4_1.raw	2	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 65	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F5_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F4_2.raw	2	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 66	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F6_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F4_3.raw	2	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 67	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F5_1.raw	3	1	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 68	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F2_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F5_2.raw	3	2	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 69	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F3_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F5_3.raw	3	3	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 70	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F4_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F6_1.raw	3	4	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 71	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F5_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F6_2.raw	3	5	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
Sample 4	Homo sapiens	ascitic fluid	C-Pool 1	not applicable	not applicable	not available	stage IV gastric cancer	not available	not available	not available	1	tissue	run 72	proteomic profiling by mass spectrometry	20150829_NoDE_cancer_high_F6_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/04/PXD003351/20150829_NoDE_cancer_high_F6_3.raw	3	6	AC=MS:1002038;NT=label free sample	NT=Q Exactive;AC=MS:1001911	AC=MS:1001251;NT=Trypsin	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	not available	not available	stage IV gastric cancer	no depletion	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
